{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:59:52Z","timestamp":1790787592023,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"DOI":"10.7759\/cureus.85455","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:24:51Z","timestamp":1749205491000},"source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic Plasmacytoma Presenting as Acute Pancreatitis: An Unusual Extramedullary Onset of Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Bakr","family":"Alhayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Gummalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12029\u2011011\u20119314\u20119","article-title":"Pancreatic involvement by plasma cell neoplasms","volume":"43","author":"Lopes da Silva R","year":"2012","unstructured":"Lopes da Silva R. Pancreatic involvement by plasma cell neoplasms. J Gastrointest Cancer. 2012, 43:157. 10.1007\/s12029\u2011011\u20119314\u20119","journal-title":"J Gastrointest Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.04.002","article-title":"Extramedullary disease in multiple myeloma - controversies and future directions","volume":"36","author":"Sevcikova S","year":"2019","unstructured":"Sevcikova S, Minarik J, Stork M, Jelinek T, Pour L, Hajek R. Extramedullary disease in multiple myeloma - controversies and future directions. Blood Rev. 2019, 36:32-9. 10.1016\/j.blre.2019.04.002","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jons.2019.10.002","article-title":"Pancreatic plasmacytoma: a rare but important entity for gastroenterologists, oncologists and hematologists","volume":"5","author":"Paydas S","year":"2019","unstructured":"Paydas S. Pancreatic plasmacytoma: a rare but important entity for gastroenterologists, oncologists and hematologists. J Oncol Sci. 2019, 5:109-11. 10.1016\/j.jons.2019.10.002","journal-title":"J Oncol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_159009","article-title":"Updated diagnostic criteria and staging system for multiple myeloma","volume":"35","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book. 2016, 35:e418-23. 10.1200\/EDBK_159009","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9 J","year":"2022","unstructured":"Blad\u00e9 J, Beksac M, Caers J, et al.. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 2022, 12:45. 10.1038\/s41408-022-00643-3","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani SZ","year":"2012","unstructured":"Usmani SZ, Heuck C, Mitchell A, et al.. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica. 2012, 97:1761-7. 10.3324\/haematol.2012.065698","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group","volume":"27","author":"Fern\u00e1ndez de Larrea C","year":"2013","unstructured":"Fern\u00e1ndez de Larrea C, Kyle RA, Durie BG, et al.. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013, 27:780-91. 10.1038\/leu.2012.336","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v8.i1.91","article-title":"Difficult endoscopic diagnosis of a pancreatic plasmacytoma: case report and review of literature","volume":"8","author":"Williet N","year":"2017","unstructured":"Williet N, Kassir R, Cuilleron M, et al.. Difficult endoscopic diagnosis of a pancreatic plasmacytoma: case report and review of literature. World J Clin Oncol. 2017, 8:91-5. 10.5306\/wjco.v8.i1.91","journal-title":"World J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030676","article-title":"Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: an international multicenter analysis","volume":"12","author":"Elsayad K","year":"2020","unstructured":"Elsayad K, Oertel M, K\u00f6nig L, et al.. Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: an international multicenter analysis. Cancers (Basel). 2020, 12:676. 10.3390\/cancers12030676","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29070399","article-title":"Bortezomib, lenalidomide and dexamethasone combination induced complete remission in relapsed\/refractory plasmablastic lymphoma: case report of a potential novel treatment approach","volume":"29","author":"Sabry W","year":"2022","unstructured":"Sabry W, Wu Y, Kodad SG. Bortezomib, lenalidomide and dexamethasone combination induced complete remission in relapsed\/refractory plasmablastic lymphoma: case report of a potential novel treatment approach. Curr Oncol. 2022, 29:5042-53. 10.3390\/curroncol29070399","journal-title":"Curr Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00404.x","article-title":"Autologous stem cell transplantation in patients with high-risk plasmacytoma","volume":"74","author":"Jantunen E","year":"2005","unstructured":"Jantunen E, Koivunen E, Putkonen M, Siitonen T, Juvonen E, Nousiainen T. Autologous stem cell transplantation in patients with high-risk plasmacytoma. Eur J Haematol. 2005, 74:402-6. 10.1111\/j.1600-0609.2004.00404.x","journal-title":"Eur J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1538777","article-title":"Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities","volume":"11","author":"Paner A","year":"2018","unstructured":"Paner A, Okwuosa TM, Richardson KJ, Libby EN. Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities. Expert Rev Hematol. 2018, 11:957-73. 10.1080\/17474086.2018.1538777","journal-title":"Expert Rev Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1096852","article-title":"Experts' consensus on the definition and management of high risk multiple myeloma","volume":"12","author":"Marcon C","year":"2022","unstructured":"Marcon C, Simeon V, Deias P, et al.. Experts' consensus on the definition and management of high risk multiple myeloma. Front Oncol. 2022, 12:1096852. 10.3389\/fonc.2022.1096852","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371631-pancreatic-plasmacytoma-presenting-as-acute-pancreatitis-an-unusual-extramedullary-onset-of-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:24:52Z","timestamp":1749205492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371631-pancreatic-plasmacytoma-presenting-as-acute-pancreatitis-an-unusual-extramedullary-onset-of-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.85455","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}